All of this sounds fantastic and could make Lilly an excellent buy, but before you take action, consider this warning: This ...

Lilly shares have climbed 200% since Mounjaro won regulatory approval in ... It's because these easy-to-administer drugs -- through a pen injector every week -- have delivered excellent results ...

Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...

Mounjaro, like Ozempic, is given as a once-weekly injection with a pre-filled pen. The method is simple, with the pen administering the right dose subcutaneously. Mounjaro's weekly injection ...

The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Dubbed the “King Kong” of weight loss jabs, Mounjaro, the brand name for tirzepatide ... It’s taken once a day with a self-injecting pen and in trials around 56 per cent of patients lost 10 per cent ...

Officials estimate that the weight-loss jab will be rolled out to 250,000 people over the next three years, starting with ...

The jab should be supplied in a four-dose pen, which provides a month's treatment when used once a week, Nice said. It was previously only available in single doses. Mounjaro is expected to ...